3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Prostatic Neoplasms
13
Brain Neoplasms
12
Sarcoma
7
Meningioma
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Glioma
5
Esophageal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Glioblastoma
4
Carcinoma, Hepatocellular
4
Breast Neoplasms
4
Solid Tumor, Adult
3
Rhabdomyosarcoma
3
Head and Neck Neoplasms
3
Chondrosarcoma
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Radiation Injuries
2
Pituitary Neoplasms
2
Pinealoma
2
Osteosarcoma
2
Oligodendroglioma
2
Nerve Sheath Neoplasms
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Liver Neoplasms
2
Hodgkin Disease
2
Gliosarcoma
2
Interventions
Cisplatin
57
Pemetrexed
45
pembrolizumab
18
Nivolumab
15
Carboplatin
15
Gemcitabine
14
Cyclophosphamide
13
Radiotherapy
10
atezolizumab
8
Drug Therapy
8
Platinum
7
Ipilimumab
7
Doxorubicin
7
durvalumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
tremelimumab
5
sodium thiosulfate
5
Vinorelbine
5
Radiotherapy, Intensity-Modulated
5
Interleukin-2
5
Chemotherapy, Adjuvant
5
Cerebral Decortication
5
sargramostim
4
fludarabine
4
defactinib
4
aldesleukin
4
tumor necrosis factor-alpha, CNGRC fusion protein, human
3
cediranib
3
Photochemotherapy
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mesothelioma, Malignant
×
Proton Therapy
×
Clear all
NCT05655078
2026-03-30
HIT-Meso
University College, London
Phase NA
Recruiting
148 enrolled